Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Pearce OMT"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Tyler EJ; Centre for Tumour Microenvironment, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom., Pearce OMT; Centre for Tumour Microenvironment, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom.
Publikováno v:
Cancer research [Cancer Res] 2024 Oct 15; Vol. 84 (20), pp. 3322-3323.
Autor:
Liu Y; Barts Cancer Institute, Queen Mary University of London, London, EC1M 6BQ, UK.; School of Engineering and Materials Science, Queen Mary University of London, London, E1 4NS, UK., Okesola BO; School of Life Sciences, Faculty of Medicine and Health Sciences, University of Nottingham, Nottingham, NG7 2RD, UK., Osuna de la Peña D; Barts Cancer Institute, Queen Mary University of London, London, EC1M 6BQ, UK.; School of Engineering and Materials Science, Queen Mary University of London, London, E1 4NS, UK., Li W; School of Engineering and Materials Science, Queen Mary University of London, London, E1 4NS, UK., Lin ML; Barts Cancer Institute, Queen Mary University of London, London, EC1M 6BQ, UK., Trabulo S; Barts Cancer Institute, Queen Mary University of London, London, EC1M 6BQ, UK., Tatari M; Barts Cancer Institute, Queen Mary University of London, London, EC1M 6BQ, UK., Lawlor RT; Department of Diagnostics and Public Health, Section of Pathology, University of Verona, Verona, 37134, Italy.; ARC-Net, Applied Research on Cancer Centre, University of Verona, Verona, 37134, Italy., Scarpa A; Department of Diagnostics and Public Health, Section of Pathology, University of Verona, Verona, 37134, Italy.; ARC-Net, Applied Research on Cancer Centre, University of Verona, Verona, 37134, Italy., Wang W; School of Engineering and Materials Science, Queen Mary University of London, London, E1 4NS, UK., Knight M; Centre for Bioengineering, School of Engineering and Materials Science, Queen Mary University of London, London, E1 4NS, UK.; Centre for Predictive in vitro Models, Queen Mary University of London, London, E1 4NS, UK., Loessner D; Barts Cancer Institute, Queen Mary University of London, London, EC1M 6BQ, UK.; Department of Chemical and Biological Engineering, Faculty of Engineering, Monash University, Melbourne, VIC, 3800, Australia.; Department of Materials Science and Engineering, Faculty of Engineering, Monash University, Melbourne, VIC, 3800, Australia.; Department of Anatomy and Developmental Biology, Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, VIC, 3800, Australia., Heeschen C; Pancreatic Cancer Heterogeneity, Candiolo Cancer Institute - FPO - IRCCS, Candiolo (TO), 10060, Italy., Mata A; School of Pharmacy, University of Nottingham, University Park, Nottingham, NG7 2RD, UK.; Biodiscovery Institute, University of Nottingham, University Park, Nottingham, NG7 2RD, UK.; Department of Chemical and Environmental Engineering, University of Nottingham, University Park, Nottingham, NG7 2RD, UK., Pearce OMT; Barts Cancer Institute, Queen Mary University of London, London, EC1M 6BQ, UK.
Publikováno v:
Advanced healthcare materials [Adv Healthc Mater] 2024 Jul; Vol. 13 (17), pp. e2301941. Date of Electronic Publication: 2024 Mar 22.
Autor:
Hirani P; Barts Cancer Institute, John Vane Science Centre, Queen Mary University of London, London, United Kingdom., McDermott J; Department of Histopathology, Imperial College Healthcare NHS Trust, London, United Kingdom., Rajeeve V; Barts Cancer Institute, John Vane Science Centre, Queen Mary University of London, London, United Kingdom., Cutillas PR; Barts Cancer Institute, John Vane Science Centre, Queen Mary University of London, London, United Kingdom., Jones JL; Barts Cancer Institute, John Vane Science Centre, Queen Mary University of London, London, United Kingdom., Pennington DJ; Centre for Immunobiology, Blizard Institute, Barts and the London Medical School, Queen Mary University of London, London, United Kingdom., Wight TN; Matrix Biology Program, Benaroya Research Institute at Virginia Mason, Seattle, Washington., Santamaria S; Department of Biochemical Sciences, School of Biosciences, Faculty of Health and Medical Sciences, Edward Jenner Building, University of Surrey, Surrey, United Kingdom., Alonge KM; Department of Medicinal Chemistry, University of Washington, Seattle, Washington., Pearce OMT; Barts Cancer Institute, John Vane Science Centre, Queen Mary University of London, London, United Kingdom.
Publikováno v:
Cancer research communications [Cancer Res Commun] 2024 Apr 03; Vol. 4 (4), pp. 970-985.
Autor:
Verbruggen SW; Department of Biomedical Engineering, Columbia University in the City of New York, New York, NY, 10027, USA.; Centre for Bioengineering, School of Engineering and Materials Science, Queen Mary University of London, London, E1 4NS, UK.; Department of Mechanical Engineering and INSIGNEO Institute for in silico Medicine, University of Sheffield, Sheffield, S1 3JD, UK.; Centre for Predictive in vitro Models, Queen Mary University of London, London, E1 4NS, UK., Nolan J; Centre for Bioengineering, School of Engineering and Materials Science, Queen Mary University of London, London, E1 4NS, UK.; Department of Mechanical Engineering and INSIGNEO Institute for in silico Medicine, University of Sheffield, Sheffield, S1 3JD, UK.; Barts Cancer Institute, School of Medicine and Dentistry, Queen Mary University of London, London, EC1M 6AU, UK., Duffy MP; Department of Biomedical Engineering, Columbia University in the City of New York, New York, NY, 10027, USA.; Department of Orthopaedic Surgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA., Pearce OMT; Barts Cancer Institute, School of Medicine and Dentistry, Queen Mary University of London, London, EC1M 6AU, UK., Jacobs CR; Department of Biomedical Engineering, Columbia University in the City of New York, New York, NY, 10027, USA., Knight MM; Centre for Bioengineering, School of Engineering and Materials Science, Queen Mary University of London, London, E1 4NS, UK.; Department of Mechanical Engineering and INSIGNEO Institute for in silico Medicine, University of Sheffield, Sheffield, S1 3JD, UK.
Publikováno v:
Advanced science (Weinheim, Baden-Wurttemberg, Germany) [Adv Sci (Weinh)] 2024 Jan; Vol. 11 (2), pp. e2305842. Date of Electronic Publication: 2023 Nov 15.
Autor:
Puttock EH; Queen Mary University of London, Barts Cancer Institute, John Vane Science Centre, London, EC1M 6BQ, UK., Tyler EJ; Queen Mary University of London, Barts Cancer Institute, John Vane Science Centre, London, EC1M 6BQ, UK., Manni M; Department of Biomedicine and Division of Medical Oncology, University Hospital Basel, Hebelstrasse 20, 4031, Basel, Switzerland., Maniati E; Queen Mary University of London, Barts Cancer Institute, John Vane Science Centre, London, EC1M 6BQ, UK., Butterworth C; Queen Mary University of London, Barts Cancer Institute, John Vane Science Centre, London, EC1M 6BQ, UK., Burger Ramos M; Queen Mary University of London, Barts Cancer Institute, John Vane Science Centre, London, EC1M 6BQ, UK., Peerani E; Queen Mary University of London, Barts Cancer Institute, John Vane Science Centre, London, EC1M 6BQ, UK., Hirani P; Queen Mary University of London, Barts Cancer Institute, John Vane Science Centre, London, EC1M 6BQ, UK., Gauthier V; Queen Mary University of London, Barts Cancer Institute, John Vane Science Centre, London, EC1M 6BQ, UK., Liu Y; Queen Mary University of London, Barts Cancer Institute, John Vane Science Centre, London, EC1M 6BQ, UK., Maniscalco G; Queen Mary University of London, Barts Cancer Institute, John Vane Science Centre, London, EC1M 6BQ, UK., Rajeeve V; Queen Mary University of London, Barts Cancer Institute, John Vane Science Centre, London, EC1M 6BQ, UK., Cutillas P; Queen Mary University of London, Barts Cancer Institute, John Vane Science Centre, London, EC1M 6BQ, UK., Trevisan C; Department of Women and Children Health, University of Padova and Fondazione Istituto di Ricerca Pediatrica Città della Speranza, Corso Stati Uniti 4, 35127, Padova, Italy., Pozzobon M; Department of Women and Children Health, University of Padova and Fondazione Istituto di Ricerca Pediatrica Città della Speranza, Corso Stati Uniti 4, 35127, Padova, Italy., Lockley M; Queen Mary University of London, Barts Cancer Institute, John Vane Science Centre, London, EC1M 6BQ, UK., Rastrick J; UCB Pharma Ltd, 208 Bath Road, Slough, Berkshire, SL1 3WE, UK., Läubli H; Department of Biomedicine and Division of Medical Oncology, University Hospital Basel, Hebelstrasse 20, 4031, Basel, Switzerland., White A; UCB Pharma Ltd, 208 Bath Road, Slough, Berkshire, SL1 3WE, UK., Pearce OMT; Queen Mary University of London, Barts Cancer Institute, John Vane Science Centre, London, EC1M 6BQ, UK. o.pearce@qmul.ac.uk.
Publikováno v:
Nature communications [Nat Commun] 2023 May 15; Vol. 14 (1), pp. 2514. Date of Electronic Publication: 2023 May 15.
Autor:
Nolan J; Centre for Bioengineering, School of Engineering and Materials Science, Queen Mary University of London, London E1 4NS, UK.; Centre for Predictive In Vitro Models, Queen Mary University of London, London E1 4NS, UK.; Barts Cancer Institute, School of Medicine and Dentistry, Queen Mary University of London, London E1 2AD, UK., Pearce OMT; Barts Cancer Institute, School of Medicine and Dentistry, Queen Mary University of London, London E1 2AD, UK., Screen HRC; Centre for Bioengineering, School of Engineering and Materials Science, Queen Mary University of London, London E1 4NS, UK.; Centre for Predictive In Vitro Models, Queen Mary University of London, London E1 4NS, UK., Knight MM; Centre for Bioengineering, School of Engineering and Materials Science, Queen Mary University of London, London E1 4NS, UK.; Centre for Predictive In Vitro Models, Queen Mary University of London, London E1 4NS, UK., Verbruggen SW; Centre for Bioengineering, School of Engineering and Materials Science, Queen Mary University of London, London E1 4NS, UK.; Centre for Predictive In Vitro Models, Queen Mary University of London, London E1 4NS, UK.; Department of Mechanical Engineering, INSIGNEO Institute for In Silico Medicine, University of Sheffield, Sheffield S1 3JD, UK.
Publikováno v:
Cancers [Cancers (Basel)] 2023 Jan 19; Vol. 15 (3). Date of Electronic Publication: 2023 Jan 19.
Autor:
Stanczak MA; Department of Biomedicine, University Hospital and University of Basel, 4031 Basel, Switzerland.; Bloomberg-Kimmel Institute for Cancer Immunotherapy at Johns Hopkins, Baltimore, MD 21287, USA.; Max Planck Institute of Immunobiology and Epigenetics, 79108 Freiburg, Germany., Rodrigues Mantuano N; Department of Biomedicine, University Hospital and University of Basel, 4031 Basel, Switzerland., Kirchhammer N; Department of Biomedicine, University Hospital and University of Basel, 4031 Basel, Switzerland., Sanin DE; Max Planck Institute of Immunobiology and Epigenetics, 79108 Freiburg, Germany., Jacob F; Department of Biomedicine, University Hospital and University of Basel, 4031 Basel, Switzerland., Coelho R; Department of Biomedicine, University Hospital and University of Basel, 4031 Basel, Switzerland., Everest-Dass AV; Institute for Glycomics, Griffith University, Gold Coast Campus, Gold Coast QLD4222, Australia., Wang J; Department of Biomedicine, University Hospital and University of Basel, 4031 Basel, Switzerland., Trefny MP; Department of Biomedicine, University Hospital and University of Basel, 4031 Basel, Switzerland., Monaco G; Department of Biomedicine, University Hospital and University of Basel, 4031 Basel, Switzerland., Bärenwaldt A; Department of Biomedicine, University Hospital and University of Basel, 4031 Basel, Switzerland., Gray MA; Department of Chemistry, Stanford ChEM-H, and Howard Hughes Medical Institute, Stanford University, Stanford, CA 94305, USA., Petrone A; Palleon Pharmaceuticals, Waltham, MA 02451, USA., Kashyap AS; Department of Biomedicine, University Hospital and University of Basel, 4031 Basel, Switzerland., Glatz K; Institute of Pathology, University Hospital Basel, 4031 Basel, Switzerland., Kasenda B; Division of Oncology, Department of Theragnostics, University Hospital Basel, 4031 Basel, Switzerland., Normington K; Palleon Pharmaceuticals, Waltham, MA 02451, USA., Broderick J; Palleon Pharmaceuticals, Waltham, MA 02451, USA., Peng L; Palleon Pharmaceuticals, Waltham, MA 02451, USA., Pearce OMT; Centre for Tumour Microenvironment, Barts Cancer Institute, Queen Mary University, London EC1M 6BQ, UK., Pearce EL; Bloomberg-Kimmel Institute for Cancer Immunotherapy at Johns Hopkins, Baltimore, MD 21287, USA.; Max Planck Institute of Immunobiology and Epigenetics, 79108 Freiburg, Germany., Bertozzi CR; Department of Chemistry, Stanford ChEM-H, and Howard Hughes Medical Institute, Stanford University, Stanford, CA 94305, USA., Zippelius A; Department of Biomedicine, University Hospital and University of Basel, 4031 Basel, Switzerland.; Division of Oncology, Department of Theragnostics, University Hospital Basel, 4031 Basel, Switzerland., Läubli H; Department of Biomedicine, University Hospital and University of Basel, 4031 Basel, Switzerland.; Division of Oncology, Department of Theragnostics, University Hospital Basel, 4031 Basel, Switzerland.
Publikováno v:
Science translational medicine [Sci Transl Med] 2022 Nov 02; Vol. 14 (669), pp. eabj1270. Date of Electronic Publication: 2022 Nov 02.
Autor:
Beatson R; Centre for Inflammation and Tissue Repair, Respiratory Medicine, University College London, London, United Kingdom., Läubli H; Laboratory for Cancer Immunotherapy, Department of Biomedicine and Medical Oncology, University Hospitalheinz, Basel, Switzerland.; Laboratory for Cancer Immunotherapy, Department of Internal Medicine, University Hospitalheinz, Basel, Switzerland., Pearce OMT; Barts Cancer Institute, Queen Mary University of London, London, United Kingdom., Reis CA; Instituto de Investigação e Inovação em Saú de (i3s), Universidade do Porto, Porto, Portugal.; Instituto de Patologia e Imunologia Molecular da Universidade do Porto (IPATIMUP), Porto, Portugal.; Instituto de Ciê ncias Biomé dicas Abel Salazar (ICBAS), Universidade do Porto, Porto, Portugal.; Faculdade de Medicina da Universidade do Porto (FMUP), Porto, Portugal.
Publikováno v:
Frontiers in immunology [Front Immunol] 2022 Aug 17; Vol. 13, pp. 1002679. Date of Electronic Publication: 2022 Aug 17 (Print Publication: 2022).
Autor:
Malacrida B; Centre for Tumour Microenvironment, Barts Cancer Institute, Queen Mary University of London, Charterhouse Square, London EC1M 6BQ, UK., Pearce OMT; Centre for Tumour Microenvironment, Barts Cancer Institute, Queen Mary University of London, Charterhouse Square, London EC1M 6BQ, UK., Balkwill FR; Centre for Tumour Microenvironment, Barts Cancer Institute, Queen Mary University of London, Charterhouse Square, London EC1M 6BQ, UK.
Publikováno v:
STAR protocols [STAR Protoc] 2022 Jan 11; Vol. 3 (1), pp. 101086. Date of Electronic Publication: 2022 Jan 11 (Print Publication: 2022).